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Objectives. The aim of this study was to determine whether the 
presence of residual coronary reserve can in itself identify viable 
~%~q~ents. 
Bac~ound. Experimental data suggest hat despite hypoper- 
fusion at rest, viable myocardium may exhibit persistence of 
coronary reserve. Preliminary observations in patients how that 
in basally dyssynergic areas, a residual vasodilator capability is 
present despite h~opeffusion at rest and that a flow-mediated 
increase in regional wall motion identifies residual viability. 
Methods. Fourteen patients with evidence of previous myocar- 
dial infarction, infarct-related single-vessel coronary artery dis- 
ease and impaired regional ven~rieular function at rest underwent 
positron emission viability imaging by fluorine.18 deoxyglucose. 
In addition, blood flow at rest and vasodilator capability were 
regionally evaluated in all patients by means of nitrogen-13 
ammonia. 
Results. Of a total of 252 segments, 133 were dyssynergie at 
rest. Of these 133 segments, 60 (group 1) showed normal meta- 
bolic activily and only mild reduction in myocardial blood flow. 
The other 73 segments howed a marked reduction in flow;, of 
these, 25 (group 2, viable) had persistent metabolic activity, 
whereas 48 (group 3, necrotic) did not. Despite similar levels of 
hypoperfusion at rest, group 2 segments howed a preserved 
coronary reserve that was virtually absent in necrotic segments 
(2.6 --. 1.3 vs. 1.3 ± 0.5, p < 0.01). This value was similar to that 
observed in viable group I segments (2.5 ± 1.6, p = NS). 
Conclusions. In addition to characterizing myocardium at risk, 
imaging of coronary flow at baseline and after dipyridamole by 
positron emission tomography provides helpful information on 
myocardial viability that may integrate the "static" viability 
information obtained with the baseline flow/metabolic approach. 
(J Am CoU Cordio11995;26:342-50) 
In recent years, the development of positron emission tomog- 
raphy as a means of noninvasive quantitatien of myocardial 
blood flow in humans has paralleled the increasing use of 
coronary leserve as an important clinical index in the charac- 
terization of patients with ischernic heart disease (1,2). A 
maintained pharmacologic coronary reserve in regions with 
h)9operfusion at rest supplied by both native and collateral 
circulation was recently demonstrated by positron emission 
tomography in patients without previous myocardial infarction 
(3,4). The presence of such a vasodilating capacity despite a
va~able degree of rest hypoperfusion is in accordance with the 
results of animal studies (5-7) in which acute as well as 
prolonged lsehemia did not completely abolish coronary re- 
serve. The clinical meaning of a persistent vasodiiator reserve 
in pat ients with previous myocardial infarction and wall motion 
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abnormalities at rest is still unknown. In fact, these patients are 
usually the target of viability protocols that do not require the 
administration of either adenosine or dipyridamole. In these 
patients, viability information derives mostly from the assess- 
ment of myocardial flow distribution with nitrogen-13 (N-13) 
ammonia and metabolic activity with fluorine-18 (F-18) deoxy- 
glucose (8). Only a few investigators (9-11) specifically ad- 
dressed the quantitative evaluation of baseline coronary blood 
flow, which was reduced both in segments with and without 
persistent metabolic activity. Among these, Gewirtz et al. (11) 
recently reported that in patients with previous myocardial 
infarction, myocardial viability is unlikely when basal regional 
myocardial blood flow is <25 ml/min per 100 g or when 
dyskinesia spresent. 
We (12) recently demonstrated that dipyridamole..induced 
improvement of contractile function in dyssynergic segments at
rest reliably identifies tissue viability when these findings are 
compared with recovery of function after revascularization. 
The potential mechanism--increased flowin viable but not in 
necrotic areas--cannot befully investigated with echocardiog- 
raphy. The quantitation of flow during dipyridamole adminis- 
tration might help to understand the meaning of maintained 
pharmacologic coronary reserve in patients with previous 
myocaidial infarction and its role in the potential recovery of 
function after revasculadzation. 
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Table 1. Clinical and Angiographie Data for 14 Patients With Coronary Artery Disease and Regional Wall Motion Abnormalities 
Coronary Anator,.,y 
MI-PET (% cross-sectional a:*.a 
Pt Age (yr)/ Acute Interval ECG reduction) Wall Motion 
No. Gender MI (mo) CK O Waves LAD LCx RCA EF Analysis by Echo 
1 70/M NA NA NA Ant 100 0 0 0.51 Ant Ap Hy 
2 55/M NA NA NA Ant 100 0 0 0.40 S Ant Lot Hy 
3 58/M NA NA NA Ant 0 73 0 0.53 Lot P Hy 
4 52/M Ant 3 NA Ant 100 0 0 0.39 Ant Hy; Ap Ak 
5 62/F Ant 3 1,476 ~lt 100 0 0 0.45 Ant Hy; Ap Ak 
6 68/M Ant 12 1,580 Ant 100 0 0 0.48 Ant SAp Ak 
7 58/M Ant 32 2,280 Ant 100 0 0 0.48 SHy;, Ant Ap Ak 
8 48/M Ant 3 1,158 Ant 83 0 0 0.48 Ant S Ap Ak 
9 62/M Lot 13 3,360 Lot 0 87 0 ~1.44 Lat P Ak 
10 56/M lnf-!.at 11 1,830 l,at 0 79 0 0.38 lnf Hy; Lat Ak 
l l  68/M Ant 6 787 Ant 92 0 0 0.46 Ant Ap Ak 
12 56/M Ant 6 5,480 Ant 100 0 0 0.45 Ant SAp Ak 
13 60/M Ant 120 664 Ant 100 0 0 0.39 Ant S Ap Ak 
14 58/M Ant 3 1,600 Ant 90 0 0 0.54 Ant SAp Hy 
Ak = akinesia; Ant = anterior; Ap = apical; CK = serum concentration f creatine kinase; D = dyskinesia; ECG = electrocardiographic; Echo = two-dimensional 
echocardiography; EF = ejection fraction by contrast ventrienlography; F =female; Hy = hypokinesia; lnf = inferior; LAD = left anterior descending coronary artery; 
Lat = lateral, LCx --: left circumflex coronary artery; M = male; MI = acute myocardial infarction; NA = not available; PET = positron emission tomography; P = 
posterior; Pt = patient; RCA = right coronary artery; S = septal. 
The aims of this study were 1) to quantitate coronary blood 
flows at baseline and with dipyridamole administration i
dyssynergic segments characterized asviable or necrotic ac- 
cording to the classic approach of positron emission tomogra- 
phy (i.e., flow/metabolism atch or mismatch), and 2) to 
correlate coronary anatomy with regional function and resid- 
ual vasodilator reserve. 
Methods 
Study patients. We studied 14 patients (mean age 59 _+ 6 
years, range 48 to 70) with documented previous myocardial 
infarction, single-vessel infarct-related coronary artery disease, 
abnormal left ventricular .?jection fraction and regional wall 
motion abnormalities atrest. Exclusion criteria were unstable 
angina, arterial hypertension, left ventricular hypertrophy, 
valvular heart disease or other detectable cardiac disorders, 
asthma, obstructive pulmouary disease or diabetes mellitus. 
Because of ,*he limited anatomic resolution of our positron 
emission tomographic studies with respect to the inferior wall, 
patients with inferior myocardial infarction were excluded. 
Because of the still unknown myocardial kinetics of F-18 
deoxyglucose in the heart of patients with diabetes mellitus, 
these patients were also excluded. All 14 study patients had a 
history of prolonged (>2-h) typical chest pain at rest; docu- 
mentation of persistent ST segmer~t elevation was available in 
11 patients; all 14 showed pathologic Q waves at the time of the 
study (Table 1). Peak serum level for creatine kinase averaged 
2,0J9 + 1,441 U/liter. The time interval between acute myo- 
cardial infarction and the study was 19 _+ 34 months (range 3 
to 120). No patient was receM,g beta-adrenergic blocking 
agents, nitrates or calcium channel antagonists at the time of 
the study. 
Two-dimensional echocardiography. A coaiaiercially avail- 
able wide angle phased array imaging system (Hewlett-Packard 
77020) and a 3.5-MHz transducer were used. Images wcfe 
acquired in standard views and were recorded on videotape for 
off-line analysis. The left ventricle was divided into 13 segments 
according to a classification modified from the guidelines of 
the American Society of Eehocardiography (13). Wall motion 
in all segments was assessed visually by two observers who had 
no knowledge of clinical and angiographic data; discrepancies 
in assessment were resolved by consensus. Segmental wall 
motion was graded by using a score index ranging from 1 
(normokinesia) to4 (dyskinesia). Regional wall motion anal- 
ysis was based only on echocardiographic fiadings. 
Coronary angiography and ventriculography. All patients 
underwent coronary angiography in multiple projections. Dig- 
ital computer-assisted calipers (Mipron, Kontron, Germany) 
were used to measure stenotic arterial segments that were 
quantified as minimal cross-sectional reas. Steno~es of >50% 
reduction of the normal cross-sectional rea were considered 
significant. Collateral circulation was graded visually on a 
4-point scale, depending on the degree of opacification of the 
occluded vessel, as previously described (14). Arteries with 
partial or complete filling of the epicardial segment by collat- 
eral channels (grades 2to 3) were defined as having an efficient 
collateral circulation. Left ventricular ejection fraction was 
calculated from contrast ventficulographic studies according to 
standard protocols. 
Positron emission tomography. An ECAT 111 positron 
tomograph (Siemens/CTl) that provides three simultaneous 
cross sections of the heart (two from the primary planes and 
one from the interplane) was used. Regional myocardial b ood 
flow was assessed with N-13 ammonia nd exogenous glucose 
utilization with F-18 deoxyglucose. A 2-day protocol was used 
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in which rest and dipyridamole N-I 3 ammonia nd rest F-18 
deoxyglucose tudies were performed in random sequence in 
all patients. N-13 ammonia (15 to 20 mCi) was infused as a 
slow bolus over 10 to 20 s. Dynamic tomographic data acqui- 
sition started simultaneously, as previously described (15). 
After acquisition of the baseline study, a period of 50 min was 
allowed for the physical decay of N-13 ammonia. Thereafter, 
dipyridamole (0.56 mf,/kg body weight in 4 rain) was infused 
intravenously under continuous electrocardiographic (ECG) 
monitoring. The second injection of N-13 ammonia was started 
2 to 3 rain after the end of dipyridamole infusion and the 
dynamic tomographic data acquisition followed the same pro- 
tocol used in the baseline study. No substances con',air_ing 
methylxanthines were ingested in the 12 h before the stady. To 
antagonize the effects of dipyridamole, aminophylline (120 to 
240 rag) was injected 3 min after the dipyridamole N-13 
ammonia injection in all patients. 
For the metabolic study all patients fasted overnight and 
undelwent oral glucose loading (50 g) 30 rain before F..18 
deoxyglucose injection. F-18 deoxyglucose (7 to 10 mCi) was 
injected intravenously and 60 rain was allowed for myocardial 
uptake. Cross-sectional imaging was performed at the same 
spatial evels used for N-13 ammonia by aligning a felt pen 
marker on the patient's chest with the laser beam of the 
tomograph. Each study was corrected for photon attenuation 
by using its own transmission scan. In control segments, count 
rates were, respectively, 17 +__ 10 and 7.6 +_ 4 counts/s per pixel 
for N-13 ammonia nd ~'-18 deoxyglucose. 
Image analysis. In each patieat he two planes that better 
represented the left ventricular walls were analyzed. Each 
tomographic plane was divided into three anatomic segments: 
septal, anterior and posterolateral. Each segment was further 
divided into three parts; consequently, regional analysis was 
performed on a total of 252 segments, with each segment 
scored as normal, hypokinetic or akinetic/dyskinetic a cording 
to wall motion observed in the corresponding main anatomic 
region (i.e., septal, anterior, lateral or posterior). The mass of 
segments ranged from 0.6 to 1 g. Images were analyzed by 
using circumferential profiles. The program normalized the 
recovered F-18 deo~glucose and N-13 ammonia counts within 
each myocardial segment to the maximal activity. To avoid 
underesti:nation of tracer uptake in dyssynergic segments, 
regional ~:ounts in these regions were also normalized to the 
maximal uptake detected in control areas with normal wall 
motion, not correlated to the diseased vessel and remote from 
the infarct zone. Segmental activity was then expressed as 
percent of tnaximal myocardial activity. A group of segments 
with normal wall motion by echocardiography, normal feeding 
coronary a:tery and remote from the infarct zone served as 
reference :or control segmental N-13 ammonia and F-18 
deoxygluct,se uptake. Infarct areas were defined as those 
showing ia two or more conti~uous egments concordant 
reduction in both normalized N-13 ammonia nd F-18 deoxy- 
glucose c,3rmts by >2 SD below the control values. Those 
segments it,which the positive difference of FAg deoxTglucose 
minus N-13 ammonia-normalized uptake exceeded 2 SD of 
the control difference in two or more contiguous egments 
were classified as viable, as previously described (8). 
Absolute myocardial blood flow was computed according to 
a method previously validated in our laboratory (16). Briefly, a 
small region of interest was drawn within the left ventricular 
cavity, and the time-activity curve inside this region was plotted 
and corrected for decay and dead time loss. Regional myocar- 
dial blood flow (rMBF) times N-13 ammonia myocardial 
extraction was calculated according to the equation: rMBF = 
Cm x 60/fCb(t) ×dt,  where Cm and Cb are N-13 ammonia 
concentrations in the myocardium easured in the last frame 
and il~ the arterial blood at each time (t), respectively. The 
initial portion of the curve Cb(t) was fitted by a gamma-variate 
function and its integral was used as input function. The 
abso;ute values of regional myocardial blood flow were cor- 
rected for the loss in linearity between N-13 ammonia uptake 
and blood flow by using a previously described algorithm (16) 
and expressed as ml/min per 100 g after correction for tissue 
gravity (1.08 g/min). Coronary reserve was calculated as the 
ratio between dipyridamole and baseline coronary blood flow. 
In a group of normal subjects studied in our laboratory (3) with 
the same technique, coronary flow reserve was 3.64 +_ 1.76. 
Statistical analysis. Data are presented as mean value _+ 
SD. For comparison of differences, appropriate t tests for 
independent orpaired samples were employed. The chi-square 
analysis was performed to determine the significance in rate of 
occurrence. For all comparisons, a p value < 0.05 was consid- 
ered significant. 
Results  
Clinical and angiographic data. The mean left ventricular 
ejection fraction at rest was 0.43 +_ 0.06 (range 0.29 to 0.54). 
The average reduction in the coronary cross-sectional area was 
93 +_ 9%. The left anterior descending coronary artery was the 
single stenotic vessel in 11 patients and the left circumflex 
artery in the remaining 3. Eight patients howed 100% occlu- 
sion of the infarct-related coronary artery with an efficient 
collateral circulation in two. On the basis of echocardiography, 
14 segments were hypokinetic and 21 akinetie (Table 1). No 
patient had inferior infarction according to inclusion criteria. 
In the 11 patients with an anterior infarction by ECG, regional 
function was abnormal in the anterior, septal or apical seg- 
ments of the left ventricle. In the two patients with a lateral 
infarction, the lateral wall was always involved, Only one 
patient showed Q waves in the anterior wall but had a normal 
left anterior descending coronary artery associated with pos- 
terolateral hypokinesia nd significant stenosis of the left 
circumflex coronary artery. Thus, all patients howed a strict 
anatomic orrespondence b tween stenotic vessel and dysfunc- 
tioning segment. 
Electrocardiographic and hemodynami~ :esponse to dipyr- 
~damole. Infusion of 0.56 mg/kg of dipyridamole over 4 rain 
was completed in all patients. Typical chest pain developed in
eight patients and diagnostic (>1.5 ram) ST segment depres- 
sion in seven. Atypical chest pain developed in two patients, 
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and one patient reported nausea. No arrhythmias were de- 
tected by continuous ECG monitoring during dipyridamole 
infusion. Baseline systolic blood pressure and heart rate aver- 
aged 138 _ 17 mm Hg and 66 - 13 beats/rain, respectiw'. 
After dipyridamole infusion, systolic blood pressure was 142 +, 
22 mm Hg (p = NS) and heart rate increased to 88 +_ 11 
beats/min (p < 0.05). Mean blood pressure did not change 
significantly from the baseline value (100 +_ 13 mm Hg vs. 
104 +, 11 mm Hg at baseline, p = NS). Rate-pressure product 
increased from 9,382 beats/rain x mm Hg at rest to 12,633 
beats/miu x mm Hg after dipyridamole infusion (p < 0.05). 
Characterization of viable and necrotic segments by meta- 
bolic/flow mismatch. On the basis of echocardiographic crite- 
ria, 119 tomographic segments were classified as having normal 
and 133 as having abnormal wall motion. Baseline control 
coronary blood flow, obtained in normal contracting segments 
not contiguous and not related to the infarct artery, was 100 ± 
24 ml/min per 100 g. This value was not different from that we 
obtained (3) in a control group of normal subjects at rest. 
According to this distribution, the lower limit for normal 
regional blood flow at rest was set at 52 ml/min per 100 g 
(mean - 2 SD). Coronary flow reserve in these segments 
averaged 2.76 +-. 72. These segments also provided the control 
regional percent value and positive difference between F-18 
deoxyglucose and N-13 ammonia uptake. 
One hundred thirty-three segments were dyssynergic at 
rest. Of these, 60 (group i) showed a baseline regional blood 
flow that was still within control imits. In these segments, the 
average F-18 deoxyglucose uptake was 81 +_ 13% and was 
higher than the lower control imit (62%) in all segments. As 
described before, each of the 73 hypoperfused segments with 
flGw <52 ml/min per 100 g was considered viable or necrotic 
Figure 1. Bar graphs how the differences in blood flow at baseline 
conditions and after dipyridamole administration in segments of
groups 1, 2 and 3 with wall motion abnormalities at rest• Baseline flow 
is similarly reduced insegments in groups 2and 3 and, after dipyrid- 
amole, increases significantly only in viable segments of groups 1and 
2. Despite similar baseline flows, only viable segments show a main- 
tained coronary eserve that is not appreciable in group 3 segments 
with evidence ofmyocardial necrosis. *p < 0.01. 
according to the presence or absence of metabolic/flow mis- 
match. Twenty-five segments (group 2) were classified as viable 
and 48 (group 3) as necrotic. Regional F-18 deoxyglueose 
uptake was 83 +-- 10% and 43 +_ 12% of the peak in group 2 and 
group 3, respectively (p< 0.01). When segments were normal- 
ized relative to the control zone, no segment from groups 1 and 
3 showed significant changes. Only six segments, all from group 
2, showed a minimal increase in F-18 deoxyglucose uptake. 
However, average F-18 deoxyglucose uptake increased to 86 - 
9% of the peak, and this value was not statistically higher than 
that obtained by using the first type of normalization (p = NS). 
Baseline and dipyridamole coronary blood flow in dyssyn- 
ergic segments, The 60 dyssynergic segments ofgroup 1 had a 
mean baseline coronary blood flow of 69 +_ 14 ml/min per 
100 g, which increased to 164 +- 70 ml/min per 100 g after 
dipyridamole administration. Coronary reserve was 2.5 +- 1.6 
(Fig. 1). Although segments of groups 2 and 3 showed similar 
rest coronary blood flow (42 +_ 12vs. 39 +_ 27 ml/min per 100 g, 
p = NS), dipyridamole flow was significantly higher iu seg- 
ments of group 2 (107 +_ 50 vs. 49 +- 18 ml/min per 100 g, p < 
0.01). Coronary reserve averaged 2.6 -+ 1.3 and 1.3 +_ 0.5 in 
segments of group 2 and group 3, respectively (p< 0.01) (Fig. 
1). Despite the obvious differences in baseline coronary blood 
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Baseline Dipyridamole 
Hgure 2. Positron emission tomo- 
grams obtained from a representa- 
tive patient in group 2. The hy- 
poperfused anterior segment (left) 
shows significant fluorine-18 de- 
oxyglucose uptake (74%) (right) 
that is associated with an increase 
of myocardial blood flow after di- 
pyridamole administration (cen- 
ter). In this segment, a coronary 
reserve of 2.5 can be used as an 
index of tissue viability. 
flow, coronary reserve in viable segments of groups 1 and 2 did 
not differ statistically. In terms of segmental response, 40% of 
segments of group 2 showed an increase in wall motion score 
index after dipyridamole. By contrast, only 9% of segments of 
group 3 showed a further eduction in regional contractility. 
Frequency distlibution analysis identified the value of cor- 
onary flow reserve of 1.65 as that providing the best separation 
between viable and necrotic segments. When the 133 segments 
with wall motion abnormalities were analyzed by using this 
cutoff value, 84 segments howe6 a maintained coronary 
reserve, whereas 49 did not. Of the 84 segments with main- 
tained coronary reserve, 71 (84%) were viable on conventional 
metabolic/flow analysis. When the 49 segments with subthresh- 
old coronary reserve were analyzed, 39 (80%) showed a 
negative match pattern and thus were correctly identified as 
necrotic. Average normalized F-18 deoxyglucose uptake was 
76 +_ 20% and 59 _ 20% of the peak in the viable and necrotic 
groups, respectively (p < 0.01). Two examples of hypoperfu- 
sion at rest associated with persistent reserve in one patient in 
group 2 and abolished coronary reserve in one patient in group 
3 are represented in Figure 2 and Figure 3, respectively. 
Relation between the degree of segmental mechanical dys- 
function and metabolism and perfusion. On echocardiogra- 
phy, dyssynergic segments were classified as hypokinetic or 
akinetic; no dyskinetie segment was found. Metabolic activity 
in hypokinetic and akinetic segments was higher in group 2 
(86 -+ 9% and 82 - 9%; 44 _ 10% and 42 +_. 13% of the peak, 
p < 0.01, respectively). The degree of hypoperfusion at rest 
was similar in both groups irrespective of the degree of 
mechanical dysfunction (39 _ 7 vs. 41 -+ 12 ml/min per 100 g 
in hypokinetic segments and 43 - 14 vs. 39 + 10 ml/min per 
100 g in akinetic segments, p = NS, respectively). After 
dipyridamole administration, myocardial b ood flow minimally 
increased only in hypokinetic segments of group 3, whereas in 
group 2 the increase was consistent inall dyssynergic segments 
and significantly higher in hypokinetic than in akinetic sectors 
(140 +-- 62 vs. 89 +_ 30 ml/min per 100 g, p < 0.01) (Fig. 4). 
Degree of coronary stenosis, collateral circulation and 
regional function. The 119 segments with normal wall motion 
were perfused by normal coronary arteries except for 6 seg- 
ments that were spatially related to a left circumflex coronary 
artery with <50% stenosis. The left anterior descending coro- 
nary artery was the infarct-related vessel in 11 patients and the 
left circumflex artery in 3. No patient had right coronary artery 
stenosis. In group 1, the reduction in cross-sectional rea of 
segments averaged 86 +- 11% and 27 segments were perfused 
by an occluded coronary artery that showed an efficient 
collateral circulation in 12. In group 2, segment~ showed an 
average coronary stenosis of 86 _+ 9% (p = NS vs. group 1); 
seven segments were related to an occluded coronary artery 
................ , . . . . . . ,  
!i!i i!! 
........ i. . . . . . .  
i 
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Figure 3. Positron emission to- 
mograms from a patient in group 
3. The hypoperfused anterior 
segment a baseline (leR) shows 
the same level of flow detected in 
the patient represented in Figure 
2. Despite similar hypoperfusion 
at rest, this segment is classified 
as necrotic on the basis of fluo- 
rine-18 deoxyglucose metabolic 
activity. (3,l% uptake) (right). 
The presence ofmyocardial scar 
is correlated with the minimal 
increase of regional blood flow 
after dipyridamole administra- 
tion (center). 
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Figure 4. Basal and dipyridamole r gional myo- 
cardial blood flow (MBF) in hypokinctic and 250 
akinetic segments ofgroups 2 and 3. No difference ,-- 
is cvident among baseline blood flow in the four 
subgroups; however, both viable hypokinetic and ~ aoo 
akinetic segments ignificantly increase regional "~ 
blood flow after dipyridamole administration, '~..I. tso- 
whereas necrotic segments do not. Hypokinetic "~ 1oo 
viable segments show an increase in regional ~' 
blood flow that is greater than that observed in ~ z0 
akinetic viable segments. *p< 0.01. ~[ 
0 
[ [ ]  Basal [ ]  D ipyr idaa~ 
Hypokinetic segments 
¢--~----n 
Group 2 
(viable) 
Akinetie segments 
2so F 
r'NS'~ / r'-~-'.~ c-NS"~ 200 [
150 r,ool 
Group $ Grou? 2 Group 3 
(necrotic) (viable) (r~rotic) 
and two of them showed an efficient collateral circulation. In 
group 3, the average reduction i  cross-sectional rea was 97 _+ 
6% (p < 0.01 vs. groups 1 and 2). Thirty-five segments were in 
the distribution territory of an occluded left anterior descend- 
ing coronary artery' that showed an efficient collateral circula- 
tion in only one segment. In group 3, segments howed a 
greater prevalence of akinesia (73%) than that in viable 
segments (64% and 50% in group 1 and group 2, respectively). 
Thus, necrotic segments in group 3 were more likely to be 
akinetic, perfused by an occluded vessel and less collateralized 
than were viable segments in groups 1 and 2 (Table 2). 
Discussion 
Among the noninvasive t chniques proposed to investigate 
myocardial viability, positron emission tomography represents 
the most reliable onz when rest flow and metabolic maging are 
associated. In this study, we added to the traditional positron 
emission tomograpbic approach the quantification fcoronary 
blood flow both at rest and after dipyridamole administration 
by using N-13 ammonia. Our results fit with the concept that 
the persistence of coronary reserve in a dyssynergic segment, 
even one with hypoperfusion at rest, reflects residual viability. 
In the following discussion we briefly review experimental 
findings pertinent to the problem of persistent coronary re- 
serve despite hypopeffusion at rest, discuss the relation be- 
tween coronary reserve and severity of dyssynergy and sum- 
marize the limitations of the study. 
Experimental correlates of coronary reserve. The associa- 
tion of significant hypoperfusion at rest with a persistent 
vasodilator reserve has been previously demonstrated in ex- 
perimemal models of significant flow reduction (5-7). Several 
investigators (5,17,18) reported that the reduction in rest 
myocardial perfusion secondary to coronary stenosis preva- 
lently occurs in the maximally vasodilated subendocardium; in 
this condition dipyfidamole may increase flow through the 
abolition of subepicardial residual vascular tone (18). Con- 
versely, Aversano and Becker (6) and Canty and Klocke (7) 
showed, in the experimental model of coronary perfnsion at a 
constant pressure, that reductions in coronary artery pressure 
ranging from 80 to 35 mm Hg resulted in a decreased perfusion 
in all layers, despite a residual vasodilating capability in both 
the subendocardium and the subepicardium. Chilian and 
Layne (19), using direct measurement of coronary microvessel 
caliper, demonstrated apc ,  sistent vascular tone despite a 
marked reduction in endoluminal pressure. Unfortunately, 
because of the limited spatial resolution of positron emission 
tomography, transmural differences in regional myocardial 
biood flow could not be investigated in the present study. 
Patients with preserved tissue viability showed similar values of 
coronary reserve, despite different degrees of both bypoperfu- 
sion and ventricular dysfunction at rest. These observations 
might strongly support he hypothesis that a preserved vasodi- 
lating capability, probably greater in the subepicardial !avers, is 
indicative of tissue viability in human myocardium. 
Table 2. Coronary Stenosis, Percent Coronary Occlusion, Collateral Circulation a,ld Dyssynergies in 
Segments From Groups 1, 2 and 3 
Mean (+-SD) 
No. of Stenosis 
Segments (% area) Coronary Occlusion Collateral Circulation Akinesia 
Group 1 60 86 -- 8 45% 44% 50% 
Group 2 25 86 -- 9 28% 28% 64% 
Group 3 48 96 + 6 73% 3% 73% 
See text for details and statistical differences. 
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Baseline coronary blood flow and myocardial viability. The 
substrate of tissue viability of hypoperfused myocardium is the 
downregulation f perfusion/contraction matching, acondition 
that can be reversed by perfusion restoration. Dyssynergic 
segments of patients with previous infarction contain different 
combinations ofstunned, hibernated and fibrotic tissue. In this 
study, segments in group 1, which showed a moderate reduc- 
tion of coronary blood flow at rest, probably represented a 
group of segments in which a dominant stunning pattern 
occurred espite infarction that was >3 months old by inclu- 
siou criteria in all patients. In contrast, downregulation of 
function secondary to hypopeffusion observed in viable seg- 
ments in group 2 more closely reflected the condition of 
myocardial hibernation that was indistinguishable from the 
dominance of myocardial scarri~,g observed in group 3 seg- 
ments on the basis of perfusion and function alone. 
Occurrence of clinical correlates of myocardial infarction, 
such as prolonged chest pain, diagnostic ECG changes and 
enzyme release, should be the main determinant of hypoper- 
fusion in dyssynergic segments despite a similar degree of 
coronary stenosis and abnormal wall motion. In this study, we 
obse: 4ed in 45% of segments with wall motion abnormalities at
rest and a site of previous infarction, a baseli~e flow not 
different from that observed in noninfarctcd segments of 
patients with coronary artery disease (3,4). These findings 
emphasize that infarcted segments are not necessarily associ- 
ated with severe hypoperfusion at rest; similarly, severely 
hypoperfused segments are not necessarily infarcted even in 
the presence of akinesia. Furthermore, in patients with coro- 
nary artery disease, noninfarcted segments--even those sub- 
tended by angiographicallv norme.l vessels--do not necessarily 
have normal perfusion at rest (3). Gewirtz et al. (11) demon- 
strated in patients with previous myocardial infarction that 
myocardial viability is unlikely when regional blood flow is 
<25 ml/min pe~' 100 g. In agreement with their data, none of 
the seven segments ingroup 3 with a value of <25 ml/min per 
100 g showed the mismatch between regional blood flow and 
F-18 deoxyglucose uptake. Similarly, the percent of akinetic 
segments ignificantly increased from group 1 to group 3 
(Table 2). However, our data disagree in that regional blood 
flow at rest was almost he same in the majority of viable and 
necrotic segments defined according to the mismatch pattern, 
whereas the overlap was markedly reduced after dipyridamole 
administration (Fig. 1). When the same categories of relative 
hypoperfusion used by Gewirtz et al. (<50% of maximum = 
infarct zone) are used, 33 segments in our study showed a 
relative flow that was <50% of the peak and thtls were 
classified as infarct zones. No difference in baseline flow was 
found with regard to the presence or absence of tissue viability 
(myocardial blood flow at rest 38 _ 10 vs. 35 +_ 11 ml/min per 
100 g, respectively, p = NS). The inclusion by Gewirtz et al. of 
patients with multivessel disease in whom the definition of 
"normal" was based only on seven segments that showed a 
coronary stenosis <50% could partly explain these discrepan- 
cies. These observations confirm the partial adequacy of 
perfusion data alone in the differentiation of viable from 
infarcted myocardium at rest. They also demonstrate the 
importance of a correct correspondence of territories explored 
by different imaging modalities (i.e., echocardiography and 
positron emission tomography) as was probably achieved in 
our clinical model of patients with single-vessel disease. 
The role of coronary reserve. Recently, a few investigators 
addressed the problem of coronary reserve in patients with rest 
hypoperfusion i  the absence of myocardial infarction. Parodi 
ct al. (20) demonstrated, byusing a semiquantitative approach 
and microsphere scintigraphy, a persistent vasodilating capa- 
bility despite rest hypoperfusion after papaverine administra- 
tion in patients with severe single-vessel coronary artery dis- 
ease and no previous infarction. In their study, nine patients 
had a hypoperfused territory at rest with an average coronary 
reserve of 1.3 + 0.13; however, three of these patients did not 
show wall motion abnormalities despite rest hypoperfusion, 
and no quantitative comparison can be derived from their 
study. Vanoverschelde et al. (4) used quantitative positron 
emission tomography in a study of 26 patients with collateral- 
dependent noninfarcted myocardium. In a subgroup of eight 
patients with wall motion abnormalities, rest and dipyridamole 
blood flow averaged 77 +_ 25 and 112 _ 44 ml/min per 100 g, 
respectively. The average baseline flow in their study was 
similar to that observed in our study only in segments of our 
group I, which were selected on the basis of normal or near 
normal perfusion, whereas amore severe, reduction in flow was 
present in segments in groups 2 and 3. Coronary reserve in the 
viable segments of our groulrs 1 and 2 was higher than that 
reported by Vanoverschelde et al., although these segments 
showed an average coronary stenosis and a rate of coronary 
occlusion that were somewhat lower than those reported by 
those investigators. Furthermore, viable segments in our study 
were characterized by a high grade of efficient collateral 
circulation. 
Sambuceti et al. (21) recently demonstrated by using 
positron emission tomography in 16 patients without previous 
myocardial infarction, single-vessel coronary artery disease and 
abnormal wall motion, hypoperfusion at rest in the stenotic 
territory (mean flow 66 __ 19 ml/min per 100 g) and a 
maintained, although reduced, vasodilator response induced 
by dipyridamole. Again, baseline coronary blood flow was 
similar to that obtained in viable segments in our group 1 but 
was higher than that obtained in segments in our groups 2 and 
3; furthermore, coronary reserve observed by Sambuceti et al. 
in relation to dyssynergic segments of patients with no history 
of infarction, was lower than that reported in our study in 
viable segments ingroups 1 and 2. The lower degree of average 
coronary stenosis measured by quantitative analysis and the 
more severe reduction of coronary blood flow at baseline but 
not after dipyridamole administration could partly explain the 
finding of a higher coronary reserve observed in viable seg- 
ments of the present study. 
The finding of a residual coronary reserve in viable seg- 
ments is in line with the initial observations of Picano et al. 
(12). Those investigators demonstrated that, in patients with 
recent as well as previous myocardial infarction, the dipyrida- 
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mole-induced recovery in the contractile function of basally 
asynergic segments, probably due to the inotropic effect of 
increased flow, was able to identify viable segments identified 
by maintained thallium-201 uptake and recovery of function 
after evascularization. If the increase in contractility after low 
dose dipyridamole administration is flow mediated, as origi- 
nally described by Gregg (22), persistence ofcoronary reserve 
becomes a prerequisite for the use of vasodilators in the 
assessment of viability by using markers of myocardial func- 
tion. Despite hypoperfusion at rest, the persistence of an 
efficient coronary reserve could induce a vascular distension 
that would affect sarcomere length and thereby influence 
contractility function. Perfusion at rest was similarly reduced in 
segments in groups 2 and 3, whereas only viable segments 
showed a significant increas~ ir~ ~tow after dlpyridamole. Be- 
yond this mechanism, dipyridamole could recruit an inotropic 
reserve in viable segments also through a metabolic mecha- 
nism due to the direct protective ffect of endogenous adeno- 
sine accumulation i dependent of coronary flow or hemody- 
namic effects (23). 
Regional wall motion abnormality and perfusion. Seg- 
mental wall motion was assessed by semiquantitative analysis 
of eehocardiograms using a st:ore ranging from normal to 
dyskinesia. Although this technique is not currently able to 
accurately quantitate systolic function in absolute terms, some 
considerations may be derived from the results obtained in 
hypokinetic and akinetic segme,ats in different groups. The first 
consideration is that hypokinesia, lthough more frequent in 
viable segments, was ~iso found in 27% of necrotic segments, 
suggesting the presence of jeopardized or nontransmural ne- 
crosis in these cases. However, in both viable and necrotic 
segments, the degree of wall motion abnormality was not 
correlated to the severity of reduction i  regional blood flow at 
rest. Thus hypokinesia was not necessarily associated with 
either viability or less severe hypoperfusion. These findings are 
in agreement with similar observations (24) obtained in pa- 
tients with coronary artery disease and regional ventric, llar 
dysfunction by using positron emission tomography in associ- 
ation with nuclear magnetic resonance imaging, a technique 
that allows a more accurate,quantitative estimation of systolic 
thickening. In group 2 segments showing flow/metabolic mis- 
match, the increase in regional blood flow after dipyridamole 
administration was higher in hypokinetic than in akinetic 
segments, and this behavior was also evident in the minimal 
change in flow induced by dipyridamole in necrotic areas. 
According to these data, although the presence of hypokinesia 
did not influence the degree of hypoperfusion atrest in any 
group, a lesser degree of systolic dysfunction was correlated 
with a higher vasodilating capacity. These data suggest that the 
possible downregulation of function--i.e., hypokinesia or 
akinesia/dyskinesia--is not proportional to the degree of hy- 
poperfusion at rest but correlates wdi with coronary reserve in 
viable segments (Fig. 4). These data also indicate that the 
degree of systolic dysfunction at rest may be inaccurate in 
predicting tissue viability in a given myocardial segment and 
that flow alone cannot be considered the only mechanism 
inducing potentially reversible mechanical dysfunction. 
Limitations of the study. Our results must be considered in
the light of several limitations of the study. Regional myocar- 
dial per/usion was measured in absolute terms, whereas glu- 
cose uptake was expressed in each segment as normalized 
percent uptake. Recent studies (25) have demonstrated that 
quantitative estimates of myocardial utilization of glucose can 
be obtained by the graphic application of Patlak analysis to 
dynamic positron emission tomographic studies. Theoretically, 
this quantitative approach could contribute to a better charac- 
terization of tissue viability in patients with wall motion 
abno~'rnalities at rest. However, the accuracy of this approach 
in a model of previous infarction with significant hypoperfu- 
sion at rest has not been validated yet, whereas the regional 
relative distribution of F-18 deoxyglucose has been proved to 
trace overall utilization of glucose (8). 
In this study, we used the flow/metabolic pattern as a 
standard of viability. However, some fo!!ow-up studies (26) 
revealed that a percent of segments with the metabolic "scar" 
pattern could improve after revascularization. This finding, 
implying a loss of specificity of positron emission tomography, 
could limit the value of our reference standard of tissue 
viability. Czernin et al. (10) recently estimated tissue viability 
in patients with acute as well as previous myocardial infarction 
by measuring blood flow, glucose utilization and myocardial 
oxygen consumption. They demonstrated that the preservation 
of oxidative metabolism should facilitate the identification of 
dysfunctioning viable myoeardium. In our stud;:, we were not 
able to use this additional marker of tissue viability. Similarly, 
most of our patients did not undergo re~ascularizatior, p oce- 
dures, thus limiting the utilization of an "a posteriori" criterion 
of tissue viability. 
The limited spatial resolution of positron emission tomog- 
raphy does not allow discrimination between subendocardial 
or subepieardial layers, thus limiting the possibility of spatial 
localization of residual coronary reserve. Unfortunately, no 
alternative imaging technique is clinically available for such a 
purpose. 
Each tomographie plane was dMded into nine :,egments. 
Although this segmentation can be considered excessive, it 
allowed a direct segment by segment comparison between 
coronary flow and reserve from one side and glucose utilization 
from the other, with a spatial resolution sufficient o avoid 
superimposition of viable and necrotic tissue as well as of 
regions belonging to different vessels. 
We excluded patients with multivessel disease, a strict 
inclusion criterion that avoided interference due to superim- 
position of vascular territories or efficient collateral circulation, 
when present. Use of this method permitted us to define asily 
a control region and to set the lower normal limit of flow with 
reasonable accuracy. However, it also prevented extension of 
our results to patients with multivessel disease and severe 
impairment of global ventricular function, the more common 
target of viability studies. Finally, a prospective blinded study 
incorporating a larger group of patients with previous infarc- 
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tion undergoing coronary revascularization, a d thus providing 
an independent s andard for viability, would be required to 
corroborate our initial findings. 
Clinical implications and conclusions. The data derived 
from this study indicate that the persistence of a measurable 
coronary reserve isa reliable indicator of viable myocardium in 
infarcted territories. Quantitative evaluation of coronary flog' 
at baseline and after dipyridamole infusion makes it possible to 
perform the whole study in 60 to 90 min, thus decreasing 
artifacts due to patient movement or repositioning, the radia- 
tion dose to the patient and the cost of the procedure. 
Omission of an F-18 deoxyglucose tudy decreases the total 
scanning duration and the comparison of different omo- 
graphic sequences required to assess aflow/metabolic pattern. 
In patients with coronary artery disease, the evaluation of 
coronary reserve allows the estimation of myocardium atrisk 
in segments with normal wall motion at rest and perfusion by 
stenotic oronary arteries. In addition to characterization f 
myocardium at risk, baseline/dipyridamole flow imaging by 
positron emission tomography provides helpful information on 
myocardial viability that may integrate the "static" viability 
information obtained by the baseline flow/metabolic approach. 
In conclusion, in patients with previous myocardial infarc- 
tion, coronary reserve in segments considered viable on the 
basis of preserved F-18 deoxyglucose uptake was significantly 
higher than that in segments with a concomitant reduction of 
both F-18 deoxyglucose uptake and perfusion. Although fur- 
ther studies are required to confirm these findings, coro~'tary 
reserve seems a reliable marker of tissue viability. 
This study summarizes the work of many colleagues. Coronary angiographic and 
wall motion studies were based on the resuRs obtained by our colleagues in the 
hemodynamic and echocardiographic groups. Radiopharmaceuticals werepre- 
pared and checked by the cyclotron staff. We thank Ilaria Cirri for typing the 
manuscript and Antonio Casefii, PhD for suggestions that improved the quality 
of this report. We are also indebted toGinevra Ouarratesi for her masterful 
bibliographic research. 
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